12 studies found for:    tinnitus | Exclude Unknown | NIH
Show Display Options
RSS Create an RSS feed from your search for:
tinnitus | Exclude Unknown | NIH
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Brain Imaging of Tinnitus
Conditions: Tinnitus;   Hearing Loss
Intervention:
2 Completed New Therapy for Patients With Severe Tinnitus
Condition: Tinnitus
Interventions: Other: Sound Based and Educational Therapies;   Other: Integrated Medicine Therapies and Sound Based Education Therapies;   Other: Integrated Medicine Therapies and SBE
3 Recruiting Tinnitus Retraining Therapy Trial
Condition: Subjective Tinnitus
Interventions: Device: Conventional sound generator (SG);   Device: Placebo sound generator (placebo SG);   Behavioral: Standard of Care (SC);   Behavioral: Directive Counseling (DC)
4 Recruiting Effect of rTMS on Resting State Brain Activity in Tinnitus
Condition: Tinnitus
Interventions: Device: Repetitive Transcranial Magnetic Stimulation (rTMS) - ACTIVE;   Device: Repetitive Transcranial Magnetic Stimulation (rTMS) - SHAM
5 Completed
Has Results
Collaborative Tinnitus Research at Washington University
Condition: Subjective Tinnitus
Intervention: Device: rTMS
6 Completed Randomized Trial Of Tinnitus Retraining Therapy
Condition: Tinnitus
Intervention: Other: Counseling and Sound Therapy
7 Recruiting Vagus Nerve Stimulation (VNS) Paired With Tones for Tinnitus
Condition: Tinnitus
Interventions: Device: VNS Treatment;   Device: VNS Control
8 Terminated Gabapentin for the Treatment of Tinnitus
Condition: Tinnitus
Intervention: Drug: Gabapentin (Neurontin)
9 Completed Micronutrients to Prevent Noise-induced Hearing Loss
Condition: Noise-Induced Hearing Loss
Interventions: Dietary Supplement: Micronutrient Supplement, capsule form;   Other: Placebo, capsule form;   Drug: Dietary supplement consisting of beta-carotene, vitamins C and E, magnesium;   Other: Placebo Control
10 Completed Bevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
Conditions: Acoustic Schwannoma;   Neurofibromatosis Type 2
Interventions: Biological: bevacizumab;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
11 Completed Idiopathic Intracranial Hypertension Treatment Trial
Condition: Idiopathic Intracranial Hypertension
Interventions: Drug: Acetazolamide;   Drug: Placebo;   Behavioral: Formal weight loss counselling program
12 Active, not recruiting Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors
Conditions: Neurotoxicity;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Procedure: management of therapy complications

Indicates status has not been verified in more than two years